NASDAQ •
Healthcare •
Medical Devices •
Quote as of 07/16/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization123.17 mln
Float28.38 mln
Earnings Date08/04/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.2
Reliable
Relative Strength
99
/ 100
Top performer
Debt / Equity
6.44
Extremely leveraged
ROE
-148
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Neuronetics develops and sells a specialized medical device called the NeuroStar Advanced Therapy System, which helps adults suffering from major depression. The technology works by using magnetic pulses to gently stimulate targeted regions of the brain linked to mood, offering an alternative to medication-based treatments. Founded in 2001 and based in Malvern, Pennsylvania, the company markets its system directly to psychiatrists across the United States and in other countries.
